SACCHARIN SODIUM
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 183.0 | 0.7 | 1 | 2 | 67.0 | 0 | 0.0 |
- CAS
- 6155573
- UNII
- SB8ZUX40TY
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 80 ZINC catalogs
Known Active Genes
This compound has been observed to have activity at 10μM or less against the following gene(s).
| Name | Description | Classification |
|---|---|---|
| A6YCJ1_9METZ | Astrosclerin-3 | Unclassified / Unclassified |
| CA | Carbonic anhydrase | Unclassified / Unclassified |
| NCE103 | Carbonic anhydrase | Enzyme / Enzyme-Other |
| MTCA2 | Carbonic anhydrase 2 | Enzyme / Enzyme-Other |
| CA7 | Carbonic anhydrase 7 | Enzyme / Enzyme-Other |
| CA4 | Carbonic anhydrase 4 | Enzyme / Enzyme-Other |
| MTCA1 | Beta-carbonic anhydrase 1 | Enzyme / Enzyme-Other |
| CA2 | Carbonic anhydrase 2 | Enzyme / Enzyme-Other |
| CA12 | Carbonic anhydrase 12 | Enzyme / Lyase |
| CA6 | Carbonic anhydrase 6 | Enzyme / Lyase |
| CA14 | Carbonic anhydrase 14 | Enzyme / Lyase |
| CA9 | Carbonic anhydrase 9 | Enzyme / Lyase |
| CA1 | Carbonic anhydrase 1 | Enzyme / Lyase |
| CA5B | Carbonic anhydrase 5B, mitochondrial | Enzyme / Lyase |
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02318446 | 2015-03-01 | Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics | Phase 3 | Not Yet Recruiting |
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Buccal | Film | 2.99MG |
| Buccal | Film, Soluble | 0.57MG |
| Buccal/sublingual | Tablet | 0.4MG |
| Dental | Gel | 0.3% |
| Dental | Ointment | |
| Dental | Paste | |
| Dental | Solution | 0.15% |
| Im - Iv | Injection | 0.09% |
| Inhalation | Aerosol, Metered | 0.05% |
| Inhalation | Solution | |
| Intramuscular | Injection | 0.09% |
| Intravenous | Injection | 0.09% |
| Iv(Infusion) | Injection | 0.09% |
| Oral | Capsule | 2.02MG |
| Oral | Capsule, Soft Gelatin | 0.51MG |
| Oral | Concentrate | 0.15% |
| Oral | Dispersible Tablet | 0.36MG |
| Oral | Emulsion | |
| Oral | Liquid | 2MG |
| Oral | Powder, For Oral Solution | 60MG |
| Oral | Powder, For Oral Suspension | 0.07% |
| Oral | Powder, For Reconstitution | 29% |
| Oral | Powder, For Solution | 39.19% |
| Oral | Powder, For Suspension | 0.65% |
| Oral | Solution, Elixir | 0.3% |
| Oral | Solution, Syrup | 0.6% |
| Oral | Suspension, Liquid | 0.05% |
| Oral | Syrup | 1% |
| Oral | Tablet | 20MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 9MG |
| Oral | Tablet, Chewable | 5MG |
| Oral | Tablet, Film Coated | 2MG |
| Rectal | Solution | 0.09% |
| Rectal | Suspension | 0.04% |
| Rectal | Tablet | 0.6MG |
| Sublingual | Tablet | 6.5MG |
| Topical | Ointment |